Biodexa Pharmaceuticals (BDRX) Interest Income - Total (2019 - 2022)
Biodexa Pharmaceuticals (BDRX) posted Interest Income - Total of -$670789.1 for Q4 2020, down 4.86% sequentially from -$639714.4 in Q3 2020, and down 52072.06% YoY from N/an in Q1 2020.
Biodexa Pharmaceuticals (BDRX) Interest Income - Total (2019 - 2022) Analysis & Trends
Biodexa Pharmaceuticals has reported Interest Income - Total for 2 years, with the latest figure at -$670789.1 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biodexa Pharmaceuticals | 64,325.41 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -473,863.04 |
| Dec 31, 2022 | -473,863.04 |
| Dec 31, 2020 | -670,789.11 |
| Dec 31, 2020 | -670,789.11 |
| Sep 10, 2020 | -639,714.43 |
| Sep 10, 2020 | -639,714.43 |
| Dec 31, 2019 | -1,285.72 |
| Dec 31, 2019 | -1,285.72 |